Article Information
History
- February 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ji Wang1,2,#,*,
- Caiguangxi Deng2,#,
- Ming Liu2,#,
- Yihao Liu3,#,
- Liubing Li4,
- Zhangping Huang2,
- Liru Shang2,
- Juan Jiang2,
- Yongyong Li2,
- Ruohui Mo3,
- Hui Zhang2,5,
- Min Liu4,
- Sui Peng2,3,* and
- Haipeng Xiao1,*,&
- 1Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
- 2Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
- 3Clinical Trials Unit, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
- 4Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
- 5Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, People’s Republic of China
- ↵*Correspondence to Dr. Haipeng Xiao, xiaohp{at}mail.sysu.edu.cn; Dr. Sui Peng, pengsui{at}vip.163.com; Dr. Ji Wang, wangj683{at}mail.sysu.edu.cn
↵# These authors contributed equally to this work.
Posted February 21, 2022.
Four doses of the inactivated SARS-CoV-2 vaccine redistribute humoral immune responses away from the Receptor Binding Domain
